Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,812 | -16,765 | -15,015 | -27,168 | -23,041 |
| Depreciation Amortization | 1,043 | 697 | 349 | 2,014 | 1,507 |
| Accounts receivable | -1,181 | 188 | -1,408 | -2,849 | -1,917 |
| Other Working Capital | -700 | -785 | -2,613 | -358 | 2,730 |
| Other Operating Activity | 13,785 | 11,028 | 14,261 | 3,684 | 3,371 |
| Operating Cash Flow | $-9,865 | $-5,637 | $-4,426 | $-24,677 | $-17,349 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8 | -5 | -2 | 12,703 | 2,786 |
| PPE Investments | -364 | -248 | -150 | -1,270 | -1,152 |
| Net Acquisitions | -11 | -12 | -12 | N/A | N/A |
| Purchase Sale Intangibles | -419 | -354 | -189 | -857 | -652 |
| Other Investing Activity | -419 | -354 | -189 | -857 | -652 |
| Investing Cash Flow | $-802 | $-619 | $-353 | $10,576 | $983 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -99 | -81 | -63 | N/A | N/A |
| Common Stock Issued | 44 | 44 | N/A | 18,745 | 69 |
| Financing Cash Flow | $-55 | $-37 | $-63 | $18,745 | $69 |
| Beginning Cash Position | 24,803 | 24,803 | 24,803 | 20,159 | 20,159 |
| End Cash Position | 14,081 | 18,510 | 19,961 | 24,803 | 3,861 |
| Net Cash Flow | $-10,722 | $-6,293 | $-4,842 | $4,644 | $-16,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,865 | -5,637 | -4,426 | -24,677 | -17,349 |
| Capital Expenditure | -364 | -248 | -150 | -1,270 | -1,152 |
| Free Cash Flow | -10,229 | -5,885 | -4,576 | -25,947 | -18,501 |